Company intelligence / Profile preview
Laboratorios Silanes
- Ownership
- Private
- Employees
- ~713
- Development stage
- Commercial
Overview
Laboratorios Silanes has over eight decades of experience as a leading Mexican pharmaceutical company with an international presence. It develops, manufactures, and commercializes more than eighty pharmaceutical products across several therapeutic areas including diabetes, cardiovascular disease, gastroenterology, pain management, infectious diseases, and antivenoms. Several of its products are approved for use in Mexico and the United States. The company continues to innovate with new drug combinations currently in late-stage clinical development.
- Therapeutic areas
- GastroenterologyCardiovascularEndocrinologyImmunologyOtherNeurology
- Modalities
- Small moleculesAntitoxinsFab fragmentsCombination drugs (e.g., pregabalin/tramadol)
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Laboratorios Silanes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorios Silanes.